Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Jonathan Rosand

Neurocritical Care · Broad Institute

View

Dr. Jinsy Andrews

ALS · NYU Langone

View

Dr. Maisha Robinson

Hospice & Palliative Care · Mayo Clinic Florida

View

Dr. Michael Kentris

Epilepsy · St. Elizabeth Medical Center

View

Dr. Daniel Correa

Epilepsy · AECOM

View

Dr. Aaron Berkowitz

General Neurology · UCSF

View

Dr. Jose Hernan Posas

Sports Neurology · UVA

View

Dr. Michael Okun

Movement Disorders · UF

View

Dr. Joseph Sirven

Epilepsy · Mayo Clinic College of Medicine

View

Dr. Rachel Marie Salas

Sleep Medicine · Johns Hopkins

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Understanding Noninferiority Trials: What Stroke Specialists Should Know.

    Jan 2, 2025DOI: 10.1161/strokeaha.124.048024Journal ArticleAHA

    Written by: Fabiano CavalcanteKilian M TreurnietManon KappelhofJohannes KaesmacherHester F LingsmaJeffrey L SaverJan GrallaUrs FischerCharles B MajoieYvo B W E M Roos

    Find these authors on Roon

    JS
    Dr. Jeffrey Saver
    Vascular Neurology · RRUCLA

    Summary

    Noninferiority trials aim to prove that the efficacy, defined in terms of a key clinical outcome, of a new treatment is not meaningfully worse than that of an established active control. Noninferiority trials are important when other aspects of care can be improved, such as convenience, toxicity, costs, and safety (nonefficacy benefits). While the motivation for a noninferiority trial is straightforward, the design, execution, and interpretation of these trials is not a trivial task. Several safeguards that protect superiority trials from incorrect conclusions do not apply or even work in reverse for noninferiority trials. This review aims to provide stroke clinicians and researchers with a general overview of noninferiority trials and a deeper understanding of 10 pitfalls they should consider when designing and interpreting such trials.
    JS

    Dr. Jeffrey Saver

    Neurology · Vascular Neurology
    Ronald Reagan UCLA Medical Center
    jeffreysaver